Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Post by quinlashon Mar 11, 2024 1:55pm
97 Views
Post# 35926802

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - CANOPY GRO

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - CANOPY GROThat would depend on your research and future outlook for the Cannabis market in the US.  

Canopy is an international licensed cannabis producer with supply agreements in place overseas.  They have Canopy Medical already in place in Germany and may possibly benefit nicely from their recent decision to legalize. 

Legalization in the US is progressing on a state level basis very well with many simply giving US legalization being a matter of WHEN vs IF.  

Once the Canopy vote completes this month we will know if shareholders are in favor (as a majority) of consolidating the US operators under one set of shares.  

Those shares are independent of existing shares so the company offers a 1 to 1 conversion to Canopy USA shares for those interested.

Details on the value to convert are still scant (IMHO) so hopefully any pending news release from the company captures that value story.












<< Previous
Bullboard Posts
Next >>